Catalyst Wire Dossier Catalyst Wire Dossier

DTPa-HBV-IPV/Hib vaccine - Formulation B

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTPa-HBV-IPV/Hib vaccine - Formulation B, covering 2016-10-12 to 2016-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants [Phase 3]

See pricing